News

Your contact person

Manager PR & Communications Jan Phillip Denkers

New Entity to Develop Therapeutics Targeting RAS Pathway Mutations in Colorectal Cancer (Picture: © Indivumed GmbH)

Indivumed Joins KHR Biotech

Indivumed GmbH (“Indivumed”) CEO Dr. Hartmut Juhl and University Medical Center Mainz Professor Krishnaraj Rajalingam today announced Indivumed will be joining the newly formed KHR ...

Read more …
©metamorworks - stock.adobe.com

Fraunhofer MEVIS among Winners of InnoHealth USA 2021

Fraunhofer MEVIS is among the winning teams of the call for Ideas & Innovation of the InnoHealth USA 2021 campaign. ...

Read more …
©Sergey Nivens - stock.adobe.com

Indeed Innovation Contest: Win a humane innovation!

To build a more beautiful future we have to recode innovation. By intersecting the needs of people, planet, and business, we will create more positive ...

Read more …
Foto: Shutterstock / whiteMocca

Northern German flagship project on artificial intelligence

Artificial intelligence and healthcare are two essential growth industries for the future that are also well represented in northern Germany. The KI-SIGS (‘KI-Space für intelligente ...

Read more …